Neogen Chemicals Intrinsic Value
NEOGEN Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹433.92 | ₹347.14 - ₹520.70 | -70.0% | EPS: ₹5.12, Sector P/E: 12x |
| Book Value Method | asset | ₹303.46 | ₹273.11 - ₹333.81 | -79.0% | Book Value/Share: ₹303.46, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹433.92 | ₹390.53 - ₹477.31 | -70.0% | Revenue/Share: ₹324.62, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹578.56 | ₹520.70 - ₹636.42 | -60.0% | EBITDA: ₹128.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹1023.97 | ₹819.18 - ₹1228.76 | -29.2% | CF Growth: 15.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹433.92 | ₹390.53 - ₹477.31 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹433.92 | ₹390.53 - ₹477.31 | -70.0% | Revenue Growth: 6.0%, Adj P/E: 8.2x |
| Graham Defensive Method | conservative | ₹433.92 | ₹390.53 - ₹477.31 | -70.0% | EPS: ₹5.12, BVPS: ₹303.46 |
Want to compare with current market value? Check NEOGEN share price latest .
Valuation Comparison Chart
NEOGEN Intrinsic Value Analysis
What is the intrinsic value of NEOGEN?
Based on our comprehensive analysis using 8 different valuation methods, the estimated intrinsic value of Neogen Chemicals (NEOGEN) is ₹433.92 (median value). With the current market price of ₹1446.40, this represents a -70.0% variance from our estimated fair value.
The valuation range spans from ₹303.46 to ₹1023.97, indicating ₹303.46 - ₹1023.97.
Is NEOGEN undervalued or overvalued?
Based on our multi-method analysis, Neogen Chemicals (NEOGEN) appears to be trading above calculated value by approximately 70.0%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 4.44 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 1.5% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | 14.0% | Industry Standard: 20%+ | Above 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.48x | Industry Standard: 1.0x+ | Below 0.5x | Measures asset utilization efficiency |
Related Pages for Neogen Chemicals
Additional stock information and data for NEOGEN
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹196 Cr | ₹38 Cr | Positive Free Cash Flow | 7/10 |
| March 2024 | ₹-29 Cr | ₹-137 Cr | Negative Cash Flow | 3/10 |
| March 2023 | ₹-30 Cr | ₹-78 Cr | Negative Cash Flow | 3/10 |
| March 2022 | ₹1 Cr | ₹-72 Cr | Positive Operating Cash Flow | 6/10 |
| March 2021 | ₹84 Cr | ₹17 Cr | Positive Free Cash Flow | 7/10 |